NTQ-5082

N/A

Report date: 2026/04/17 20:02:02
NME

Base Information

Drug NameNTQ-5082
Drug Alias NameNTQ5082NTQ-5082
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionComplement factor B inhibitors
TargetsComplement factor B
Therapy Area/IndicationsHemolysisThrombocytopeniaPurpura, Thrombocytopenic, Idiopathic +[8] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesNanjing Zhengda Tianqing Pharmaceutical Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesNanjing Zhengda Tianqing Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsHemolysisThrombocytopeniaPurpura, Thrombocytopenic, Idiopathic +[8] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A